Zhejiang Chiral Medicine Chemicals Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is CARBIDOPA, with a corresponding US DMF Number 19899.
Remarkably, this DMF maintains an Active status since its submission on October 16, 2006, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 21, 2013, and payment made on December 12, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II